Price target upside
Connect Biopharma Holdings Limited - Ordinary Shares Price Target Upside or Downside
CNTB price target upside based on the current price and analyst average.
Direct answer
Connect Biopharma Holdings Limited - Ordinary Shares's analyst target implies +223.1%.
The average target is $7.13 compared with a recorded current price of $2.21.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 9, 2026.
Get free Connect Biopharma Holdings Limited - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.21
- Average price target
- $7.13
- High price target
- $10.00
- Low price target
- $4.00
- Target upside
- +223.1%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 9, 2026
- Valid through
- August 16, 2026